U.S. State Issues
Access to Therapies
PPTA works with member companies and stakeholders to obtain access to therapies, payer cost containment strategies and on issues centered around health care reform.
Comment Letters/Memos to PPTA Member Companies
- • State of Alabama Response to PPTA on Alabama Medicaid Program Decision to Implement Changes In Reimbursement of Hemophilia Factor VIII Therapie
- • PPTA Letter to Office of Pharmacy in State of West Virginia on Reimbursement for A1P1 Products
- • PPTA Letter of Support for H.2155 and H.2071 on Vital Legislation for the Bleeding Disorders Community in Massachusetts
- • PPTA Letter to Pennsylvania House Insurance Committee Chairman on Support for the Enactment of HB 1105, the “Hemophilia Standards of Care Act”
- • PPTA Letter to Arkansas Medicaid Policy Program on Arkansas Hemophilia Management Program
- • PPTA Memo to Members Outlining OIG Report Summary Related to Average Manufacturer Price
- • PPTA Letter to Arizona Senate Committee on Health – IVIG hearing Update
- • PPTA Comment letter on Deficit Reduction Act of 2005
- • PPTA Letter to State of Alabama on Medicaid Program Decision to Implement Public Health Service Based Pricing for Reimbursement of Hemophilia Factor VIII Therapies
Proclamations, Resolutions and Legislation
- • Florida – Senate Resolution Recognizing April 2007 as Plasma Protein Therapies Month
- • Maine – Joint Resolution Establishing March as Access to Plasma Protein Therapies Month
- • Minnesota – Proclamation the month of May 2007 as Plasma Protein Therapies Month
- • Texas – State Resolution Recognizing June 2007 Be Recognized as IVIG Awareness Month
- Payer Cost Containment Strategies
PPTA remains committed to preventing cost containment measures from impacting patient access to life-saving therapies. Payers frequently use cost containment measures to reduce the impact of rising health care costs. Common strategies include reducing pharmacy reimbursement, requiring patient cost-sharing, and single source provider agreements.
- • Impact of Medicaid Reimbursement - Issue Brief
- • PPTA Memo to Member Companies Summarizing Final Rule Implementing the Average Manufacturer Price Provisions of the Deficit Reduction Act of 2005
- Healthcare Reform
There are more than 45 million individuals in the United States that lack health insurance. Many states are discussing healthcare reform to address the problem of the uninsured in their state. PPTA will actively participate in these discussions to ensure that the unique health care needs of plasma protein therpaies consumers are addressed.
- • PPTA Comments on Texas Medicaid Reform Proposal
- • PPTA Memo Summarizing California Healthcare Reform Update